Ulat mula sa Department of Health and Social Care, na may pamagat na Defining the highest-risk clinical subgroups on community infection with SARS-CoV-2 kapag isinasaalang-alang ang paggamit ng neutralizing monoclonal antibodies (nMABs) at mga antiviral na gamot: independent advisory group, na may petsang 30/05/2022.